시장보고서
상품코드
1263191

세계의 마우스 모델 시장 : 모델 종류별, 서비스별, 기술별, 용도별, 최종사용자별 예측(-2028년)

Mice Model Market by Model Types & Services, Technology, Application, End User - Global Forecast to 2028

발행일: | 리서치사: MarketsandMarkets | 페이지 정보: 영문 227 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

글로벌 마우스 모델 시장 규모는 예측 기간 동안 13.9%의 CAGR로 성장하여 2023년 14억 달러에서 2028년에는 27억 달러에 달할 것으로 예상됩니다.

마우스 모델 시장의 성장을 촉진하는 주요 요인은 신약 개발 분야의 다양한 장점과 기술의 고효율성입니다. 그러나 대체 가능한 동물 연구 모델의 존재는 시장 성장을 어느 정도 억제할 것으로 예상됩니다.

"용도별로는 PDx 모델/이종 이식편 부문이 마우스 모델 시장에서 가장 큰 점유율을 차지할 것"

면역결핍 마우스 모델에서 개인 맞춤형 의료에 대한 선호도가 높아짐에 따라 PDx 모델/이종 이식편 부문이 2022년 시장을 주도할 것으로 예상됩니다. 개인 맞춤형 의료는 마우스 모델을 사용하여 설계됩니다.

"최종 사용자별로는 제약 및 생명공학 기업 부문이 마우스 모델 시장에서 가장 큰 점유율을 차지하고 있습니다."

2022년에는 제약 및 생명공학 기업 부문이 마우스 모델 시장에서 더 큰 점유율을 차지할 것으로 예상됩니다. 이 시장 부문의 성장 요인으로는 각 기업의 의약품 개발을 위한 연구개발(R♤D) 지출이 증가하고 있다는 점을 들 수 있습니다.

"북미: 마우스 모델 시장 점유율 1위"

마우스 모델 시장에서는 북미가 가장 큰 점유율을 차지하고 있습니다. 북미의 높은 점유율은 CRO(임상시험수탁기관)와 바이오제약 기업의 전임상 활동의 증가와 생물의학 연구의 대폭적인 증가에 기인하는 것으로 보입니다. 또한, 미국에는 마우스 모델 시장의 주요 기업들이 존재하여 시장 성장을 견인하고 있습니다.

"아시아 태평양 : 마우스 모델 시장에서 가장 높은 성장률을 보이는 지역"

아시아태평양의 마우스 모델 시장은 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 이는 많은 국내외 기업들이 이 지역에 진출하여 입지를 강화하는 데 기인합니다. 한편, 국내 기업들은 사업 제휴 및 협력, 계약 및 확장을 통해 국제적인 영향력을 확대하고 있습니다. 이 밖에도 개인 맞춤형 의료 및 재생의료에 대한 수요 증가, 중국 내 연구개발 활동을 위한 국제적인 제휴, 의약품 및 화장품에 대한 동물실험 의무화 등을 꼽을 수 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

  • 서론
  • 시장 역학
    • 촉진요인
    • 억제요인
    • 기회
    • 과제
  • 기술 분석
  • 고객의 비즈니스에 영향을 미치는 동향/혼란
  • 공급망과 밸류체인 분석
  • 에코시스템 분석
  • Porter의 Five Forces 분석
  • 규제 분석
  • 특허 분석
  • 가격 분석
  • 주요 회의
  • 주요 이해관계자와 구입 기준

제6장 마우스 모델 시장 : 모델 종류별·서비스별

  • 서론
  • 모델 종류
    • 서론
    • 근교계 마우스
    • 비근교계 마우스
    • 유전자 변형 마우스
    • 하이브리드/CONGENIC MICE
  • 서비스
    • 서론
    • 번식 서비스
    • 동결 보존 서비스
    • 재도출 서비스
    • 검역 서비스
    • 기타 서비스

제7장 마우스 모델 시장 : 용도별

  • 서론
  • Drug Discovery & DEVELOPMENT
  • 기초 연구
  • PDx 모델/이종 이식편

제8장 마우스 모델 시장 : 기술별

  • 서론
  • CRISPR/CAS9
  • 현미경하 주사법
  • 배성줄기세포 주입
  • 핵이식
  • 기타 기술

제9장 마우스 모델 시장 : 최종사용자별

  • 서론
  • 제약 기업 및 바이오테크놀러지 기업
  • CRO/CDMO
  • 학술기관 및 연구기관

제10장 마우스 모델 시장 : 지역별

  • 서론
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 기타 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제11장 경쟁 구도

  • 서론
  • 주요 기업이 채택한 전략
  • 매출 점유율 분석(주요 4개사)
  • 기업 평가 쿼드런트 : 국제적 기업
  • 기업 평가 쿼드런트 : 스타트업/중소기업
  • 경쟁 시나리오와 동향

제12장 기업 개요

  • 주요 기업
    • CHARLES RIVER LABORATORIES
    • THE JACKSON LABORATORY
    • INOTIV
    • GENOWAY
    • TACONIC BIOSCIENCES, INC.
    • JANVIER LABS
    • HARBOUR BIOMED
    • TRANS GENIC INC.
    • INGENIOUS TARGETING LABORATORY
    • POLYGENE
    • ARAGEN LIFE SCIENCES LTD.
    • CYAGEN BIOSCIENCES
    • CROWN BIOSCIENCE
    • TRANSCURE BIOSERVICES
    • OZGENE PTY LTD.
  • 기타 기업
    • THE ANDERSONS, INC.
    • ALLENTOWN, LLC
    • INNOVIVE
    • LAB PRODUCTS, LLC.
    • CRESCENDO BIOLOGICS
    • IMMUNOGENES
    • LEXICON PHARMACEUTICALS, INC.
    • HORIZON DISCOVERY LTD.
    • MARSHALL BIORESOURCES
    • APPLIED STEMCELL

제13장 부록

LSH 23.05.10

The mice model market is projected to reach USD 2.7 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 13.9% during the forecast period. The key factors driving the growth of the mice model market are its various advantages in the drug discovery sector, and the high efficiency of the technologies. However, the presence of alternative animal research models is expected to restrain market growth to a certain extent.

The mice model market has been segmented based on model types & services, technology, application, end user, and region.

"By application, the PDx models/ xenografts segment accounted for the largest share of the mice model market"

Based on application, the mice model market is categorized into drug discovery and development, basic research, and PDX models/ xenografts. The PDx models/ xenografts segment dominated the market in 2022, owing to the growing preference for personalized medicine in immunodeficient mice models. Personalized medicines are designed through the use of mice models.

"By end user, the pharmaceutical & biotechnology companies segment accounted for the largest share in the mice model market"

Based on end user, the Mice model market is segmented into academic & research institutions, pharmaceutical & biotechnology companies, contract research organizations (CROs) and contract development & manufacturing organizations. In 2022, the pharmaceutical and biotechnology companies' segment accounted for a larger share of the mice model market. Growth in this market segment can be attributed to the increasing expenditure on R&D by companies for drug development.

"North America: the largest share of the mice model market"

North America accounted for the largest share of the mice model market. The large share of the North America region can be attributed to a rise in the preclinical activities by contract research organizations and the biopharmaceutical companies, and a significant increase in the biomedical research. Moreover, presence of key players in the mice model market in the U.S. are propelling the growth of the market.

"Asia Pacific: The fastest-growing region in the mice model market."

The Asia Pacific mice model market is projected to grow at the highest CAGR during the forecast period. This is attributed to increasing numbers of both domestic and international market players which are focusing on increasing their prescence in the region. Meanwhile, domestic players are expanding their international reach through partnerships, collaborations, agreements, and expansions. Moreover, increasing demand for personalized medicine and regenerative medicine, international alliances for R&D activities in China, and mandatory animal testing for pharmaceutical drugs & cosmetics.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: Executives - 40%, Research Scientists- 30%, and Managers - 30%
  • By Country: North America- 22%, Europe- 42%, Asia Pacific- 11%, Latin America- 20%, and MEA- 5%

Prominent Players

  • Charles River Laboratories (US)
  • The Jackson Laboratory (US)
  • Inotiv (US)
  • genOway (France)
  • Taconic Biosciences, Inc. (US)
  • Janvier Labs (France)
  • Harbour BioMed (China)
  • Trans Genic Inc. (Japan)
  • Ingenious Targeting Laboratory (US)
  • PolyGene AG (Switzerland)
  • Aragen Life Sciences Ltd. (India)
  • Cyagen Biosciences (US)
  • Crown Biosciences (US)
  • TransCure bioServices (France)
  • Ozgene Pty. Ltd. (Australia)
  • The Andersons, Inc. (US)
  • Allentown, LLC (US)
  • Innovive (US)
  • Lab Products, LLC. (US)
  • Crescendo Biologics Limited (UK)
  • ImmunoGenes (Hungary)
  • Lexicon Pharmaceuticals, Inc. (US)
  • Horizon Discovery Ltd (UK)
  • Marshall BioResources (US)
  • Applied StemCell Inc. (US)

Research Coverage:

This report provides a detailed picture of the mice model market. It aims at estimating the size and future growth potential of the market across different segments, such as the model types and services (model types, services), technology (CRISPR/CAS9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), application (drug discovery & development, basic research, and PDx models/xenografts), end user (academic & research institutes, pharma & biotech companies, and CROs & CDMOs), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall mice model market and its segments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, opportunities, and challenges.

The report provide insights on the following pointers"

  • Analysis of key drivers (rising investments in mouse-model based research, increasing demand of mouse-based clinical trials (MCTs) for more productive outcomes, and the growing preference for personalized medicine), restraints (introduction of 3D-printed mouse models), opportunities (utilization of CRISPR in biomedical research), and challenges (development of alternative animal testing methods) . influencing the growth of the mice model market.
  • Product Development/ Innovation: Detailed insights on upcoming technologies, research and development activities, and new models & services launches in the mice model market.
  • Market Development: Comprehensive information about lucrative markets- the report analyses the mice model market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the mice model market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Charles River Laboratories (US) (US), The Jackson Laboratory (US), Inotiv (US), genOway (France), and Taconic Biosciences, Inc. (US) among others in the mice model market strategies. The report also helps stakeholders understand the pulse of the animal research model market and provides them information on key market drivers, restraints, challenges and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
  • 1.6 RESEARCH LIMITATIONS
  • 1.7 STAKEHOLDERS
    • 1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • FIGURE 4 MICE MODEL MARKET SIZE (USD MILLION)
    • FIGURE 5 MICE MODEL MARKET: FINAL CAGR PROJECTION (2023-2028)
    • FIGURE 6 MICE MODEL MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 2.3 MARKET DATA ESTIMATION AND TRIANGULATION
    • 2.3.1 DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.4 INDUSTRY INSIGHTS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RECESSION IMPACT: MICE MODEL MARKET
    • TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2023-2028 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 8 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 9 MICE MODEL MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 MICE MODEL MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 MICE MODEL MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 MICE MODEL MARKET OVERVIEW
    • FIGURE 12 INCREASING DEMAND FOR MOUSE-BASED CLINICAL TRIALS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE (2022)
    • FIGURE 13 MICE MODELS SEGMENT IN THE US ACCOUNTED FOR LARGEST MARKET SHARE
  • 4.3 MICE MODEL MARKET SHARE, BY END USER, 2023 VS. 2028
    • FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.4 MICE MODEL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE IN ASIA PACIFIC MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 4 MICE MODEL MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising investments in mouse model-based research
      • 5.2.1.2 Increasing demand for mouse-based clinical trials (MCTs)
      • 5.2.1.3 Growing preference for personalized medicine
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Introduction of 3D-printed mouse models
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Utilization of CRISPR in biomedical research
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Development of alternative animal testing methods
  • 5.3 TECHNOLOGY ANALYSIS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.5 SUPPLY AND VALUE CHAIN ANALYSIS
    • 5.5.1 MICE MODEL MARKET: SUPPLY CHAIN ANALYSIS
    • FIGURE 18 MICE MODEL MARKET: SUPPLY CHAIN MAP
    • 5.5.2 MICE MODEL MARKET: VALUE CHAIN MAP
    • FIGURE 19 MICE MODEL MARKET: VALUE CHAIN MODEL
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 20 MICE MODEL MARKET: ECOSYSTEM MAP
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 5 MICE MODEL MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 REGULATORY ANALYSIS
    • 5.8.1 INTRODUCTION
    • 5.8.2 NORTH AMERICA
    • 5.8.3 EUROPE
    • 5.8.4 CHINA
    • 5.8.5 JAPAN
    • 5.8.6 INDIA
    • 5.8.7 AUSTRALIA
    • 5.8.8 BRAZIL
  • 5.9 PATENT ANALYSIS
    • FIGURE 21 MICE MODEL MARKET: PATENT FILING TRENDS (2010-2022)
  • 5.10 PRICING ANALYSIS
    • TABLE 6 AVERAGE SELLING PRICE OF PRODUCTS BY MANUFACTURERS
    • 5.10.1 MICE MODEL MARKET: AVERAGE SELLING PRICE TREND ANALYSIS
  • 5.11 KEY CONFERENCES
    • 5.11.1 MICE MODEL MARKET: KEY CONFERENCES (2023)
    • TABLE 7 MICE MODEL MARKET: KEY CONFERENCES (2023)
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 22 MICE MODEL MARKET: INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
    • 5.12.2 MICE MODEL MARKET: KEY BUYING CRITERIA
    • FIGURE 23 KEY BUYING CRITERIA FOR END USERS

6 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE

  • 6.1 INTRODUCTION
    • TABLE 8 MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
  • 6.2 MODEL TYPE
    • 6.2.1 INTRODUCTION
    • TABLE 9 MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • 6.2.2 INBRED MICE
      • 6.2.2.1 Growing applications of inbred mice in mAb production and pharmacology to drive market
    • TABLE 10 INBRED MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 11 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 12 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 13 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 OUTBRED MICE
      • 6.2.3.1 Genetic diversity offered by outbred mice to drive market
    • TABLE 14 OUTBRED MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 15 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 16 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 17 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.4 GENETICALLY ENGINEERED MICE
      • 6.2.4.1 Increasing focus on personalized medicine for cancer and CVD to drive segment growth
    • TABLE 18 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 19 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.5 HYBRID/CONGENIC MICE
      • 6.2.5.1 Increasing demand for congenic mice in biomedical research to drive market
    • TABLE 22 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 INTRODUCTION
    • TABLE 26 MICE MODEL MARKET, BY SERVICES, 2021-2028 (USD MILLION)
    • 6.3.2 BREEDING SERVICES
      • 6.3.2.1 Growing number of mice model studies to fuel market
    • TABLE 27 MICE MODEL MARKET FOR BREEDING SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 28 NORTH AMERICA: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 EUROPE: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 ASIA PACIFIC: MICE MODEL MARKET FOR BREEDING SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 CRYOPRESERVATION SERVICES
      • 6.3.3.1 Rising need for preservation of novel mice models to drive market
    • TABLE 31 MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 32 NORTH AMERICA: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 33 EUROPE: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 ASIA PACIFIC: MICE MODEL MARKET FOR CRYOPRESERVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.4 REDERIVATION SERVICES
      • 6.3.4.1 Stringent quality assurance standards to drive market
    • TABLE 35 MICE MODEL MARKET FOR REDERIVATION SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 36 NORTH AMERICA: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 37 EUROPE: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 ASIA PACIFIC: MICE MODEL MARKET FOR REDERIVATION SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.5 QUARANTINE SERVICES
      • 6.3.5.1 Rising demand for germ-free mice in histopathology and serology applications to drive market
    • TABLE 39 MICE MODEL MARKET FOR QUARANTINE SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: MICE MODEL MARKET FOR QUARANTINE SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 EUROPE: MICE MODEL MARKET FOR QUARANTINE SERVICE, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: MICE MODEL MARKET FOR QUARANTINE SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.6 OTHER SERVICES
    • TABLE 43 MICE MODEL MARKET FOR OTHER SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 EUROPE: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)

7 MICE MODEL MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 47 MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 7.2 DRUG DISCOVERY & DEVELOPMENT
    • 7.2.1 RISING NUMBER OF CLINICAL TRIALS TO DRIVE DEMAND FOR MICE MODELS
    • TABLE 48 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 BASIC RESEARCH
    • 7.3.1 INCREASING FUNDS FOR CANCER RESEARCH ON MICE MODELS TO SUPPORT MARKET GROWTH
    • TABLE 52 MICE MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 53 NORTH AMERICA: MICE MODEL MARKET MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 54 EUROPE: MICE MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: MICE MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 PDX MODELS/ XENOGRAFTS
    • 7.4.1 GROWING PREFERENCE FOR PERSONALIZED MEDICINE IN IMMUNODEFICIENT MICE MODELS TO DRIVE MARKET
    • TABLE 56 MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 57 NORTH AMERICA: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 59 ASIA PACIFIC: MICE MODEL MARKET FOR PDX MODELS/XENOGRAFTS, BY COUNTRY, 2021-2028 (USD MILLION)

8 MICE MODEL MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 60 MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 8.2 CRISPR/CAS9
    • 8.2.1 HIGH EFFICIENCY AND COST-EFFECTIVE BENEFITS TO DRIVE DEMAND FOR CRISPR-CUSTOMIZED MODELS
    • TABLE 61 MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 62 NORTH AMERICA: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 EUROPE: MICE MODEL MARKET FOR CRISPR/CAS9 TECHNOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 ASIA PACIFIC: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 MICROINJECTION
    • 8.3.1 WIDELY UTILIZED TECHNIQUE FOR DEVELOPMENT OF TRANSGENIC MICE MODELS TO DRIVE MARKET
    • TABLE 65 NORTH AMERICA: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: MICE MODEL MARKET FOR MICROINJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 EMBRYONIC STEM CELL INJECTION
    • 8.4.1 GROWING DEMAND FOR TARGETED MICE MODELS TO DRIVE MARKET
    • TABLE 68 NORTH AMERICA: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTION, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 NUCLEAR TRANSFER
    • 8.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE TO DRIVE MARKET
    • TABLE 71 NORTH AMERICA: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 EUROPE: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 ASIA PACIFIC: MICE MODEL MARKET FOR NUCLEAR TRANSFER, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.6 OTHER TECHNOLOGIES
    • TABLE 74 NORTH AMERICA: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 75 EUROPE: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)

9 MICE MODEL MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 77 MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 EXTENSIVE USE OF MICE MODELS IN CANCER THERAPEUTICS TO DRIVE MARKET
    • TABLE 78 MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 79 NORTH AMERICA: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 80 EUROPE: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 ASIA PACIFIC: MICE MODEL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS AND CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS
    • 9.3.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE MARKET
    • TABLE 82 MICE MODEL MARKET FOR CROS AND CDMOS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 EUROPE: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 ASIA PACIFIC: MICE MODEL MARKET FOR CROS AND CDMOS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 INCREASE IN GOVERNMENT LIFE SCIENCES R&D EXPENDITURE TO DRIVE MARKET
    • TABLE 86 MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 87 NORTH AMERICA: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 EUROPE: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 ASIA PACIFIC: MICE MODEL MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)

10 MICE MODEL MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 24 MICE MODEL MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
    • TABLE 90 MICE MODEL MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 25 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT
    • TABLE 91 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 95 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 96 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Rising production of monoclonal antibodies to fuel market for mice models
    • TABLE 98 US: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 99 US: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 100 US: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 101 US: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 102 US: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 103 US: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Rising activities in stem cell research to drive adoption of mice models
    • TABLE 104 CANADA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 105 CANADA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 CANADA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 107 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 108 CANADA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 109 CANADA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 NORTH AMERICA: RECESSION IMPACT
  • 10.3 EUROPE
    • TABLE 110 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 111 EUROPE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 112 EUROPE: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 EUROPE: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 114 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 115 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 116 EUROPE: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Rising research activities in biotechnology industry to drive market
    • TABLE 117 GERMANY: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 118 GERMANY: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 GERMANY: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 120 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 121 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 122 GERMANY: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Rising research in proteomics & genomics to drive adoption of genetically engineered mice models
    • TABLE 123 FRANCE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 124 FRANCE: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 FRANCE: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 126 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 127 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 128 FRANCE: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Increasing focus on cancer research to drive market
    • TABLE 129 UK: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 130 UK: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 131 UK: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 132 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 133 UK: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 134 UK: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising demand for preclinical research in pharmaceutical & biotechnology industry to support market growth
    • TABLE 135 ITALY: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 136 ITALY: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 137 ITALY: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 138 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 139 ITALY: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 140 ITALY: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 High number of pharmaceutical laboratories to fuel market for mice models
    • TABLE 141 SPAIN: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 142 SPAIN: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 143 SPAIN: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 144 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 145 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 146 SPAIN: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 147 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 148 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 151 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 152 REST OF EUROPE: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 EUROPE: RECESSION IMPACT
  • 10.4 ASIA PACIFIC
    • FIGURE 26 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT
    • TABLE 153 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Increasing focus on advancements in mice model technologies to drive market
    • TABLE 160 JAPAN: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 161 JAPAN: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 162 JAPAN: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 163 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 164 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 JAPAN: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 International alliances for R&D activities to drive adoption of mice models
    • TABLE 166 CHINA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 167 CHINA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 168 CHINA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 169 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 170 CHINA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 171 CHINA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Rising initiatives in drug discovery development to fuel uptake of inbred mice
    • TABLE 172 INDIA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 173 INDIA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 174 INDIA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 175 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 176 INDIA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 177 INDIA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Rising R&D investments in drug development to fuel uptake for genetically engineered mice models
    • TABLE 178 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 179 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 180 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 181 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 182 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 183 SOUTH KOREA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 High number of research institutes to drive market for mouse-based clinical trials
    • TABLE 184 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 185 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 187 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 188 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 189 AUSTRALIA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 190 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 191 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 193 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 194 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 195 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.7 ASIA PACIFIC: RECESSION IMPACT
  • 10.5 LATIN AMERICA
    • 10.5.1 GROWING PHARMACEUTICAL INDUSTRY AND DRUG DEVELOPMENT ACTIVITIES TO SUPPORT MARKET GROWTH
    • TABLE 196 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 197 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 198 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 199 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 200 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 201 LATIN AMERICA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 LATIN AMERICA: RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 RISING EXPANSION OF PHARMACEUTICAL FACTORIES TO SUPPORT MARKET GROWTH
    • TABLE 202 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MODEL TYPE AND SERVICE, 2021-2028 (USD MILLION)
    • TABLE 203 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY MODEL TYPE, 2021-2028 (USD MILLION)
    • TABLE 204 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 205 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 206 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 207 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 27 MICE MODEL MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 11.3 REVENUE SHARE ANALYSIS (TOP 4 PLAYERS)
    • FIGURE 28 REVENUE ANALYSIS FOR TOP 4 COMPANIES (2020-2022)
    • FIGURE 29 MICE MODEL MARKET: MARKET SHARE ANALYSIS OF TOP 4 PLAYERS (2022)
  • 11.4 COMPANY EVALUATION QUADRANT FOR GLOBAL PLAYERS
    • 11.4.1 STARS
    • 11.4.2 EMERGING LEADERS
    • 11.4.3 PERVASIVE PLAYERS
    • 11.4.4 PARTICIPANTS
    • FIGURE 30 MICE MODEL MARKET: COMPANY EVALUATION MATRIX FOR GLOBAL PLAYERS (2022)
  • 11.5 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES
    • 11.5.1 PROGRESSIVE COMPANIES
    • 11.5.2 STARTING BLOCKS
    • 11.5.3 RESPONSIVE COMPANIES
    • 11.5.4 DYNAMIC COMPANIES
    • FIGURE 31 MICE MODEL MARKET: STARTUPS/SMES EVALUATION QUADRANT (2022)
    • 11.5.5 COMPETITIVE BENCHMARKING
      • 11.5.5.1 Mice Model Market: List of Startups/SMEs
    • TABLE 208 MICE MODEL MARKET: DETAILED LIST OF STARTUPS/SMES
      • 11.5.5.2 Mice Model Market: Competitive Benchmarking Of Key Players (Startups/SMEs)
    • TABLE 209 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
  • 11.6 COMPETITIVE SCENARIO AND TRENDS
    • 11.6.1 PRODUCT LAUNCHES
    • TABLE 210 MICE MODEL MARKET: PRODUCT LAUNCHES
    • 11.6.2 DEALS
    • TABLE 211 MICE MODEL MARKET: DEALS
    • 11.6.3 OTHER DEVELOPMENTS
    • TABLE 212 MICE MODEL MARKET: OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 12.1.1 CHARLES RIVER LABORATORIES
    • TABLE 213 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
    • FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
    • 12.1.2 THE JACKSON LABORATORY
    • TABLE 214 THE JACKSON LABORATORY: COMPANY OVERVIEW
    • FIGURE 33 THE JACKSON LABORATORY: COMPANY SNAPSHOT
    • 12.1.3 INOTIV
    • TABLE 215 INOTIV: COMPANY OVERVIEW
    • FIGURE 34 INOTIV: COMPANY SNAPSHOT
    • 12.1.4 GENOWAY
    • TABLE 216 GENOWAY: COMPANY OVERVIEW
    • FIGURE 35 GENOWAY: COMPANY SNAPSHOT (2022)
    • 12.1.5 TACONIC BIOSCIENCES, INC.
    • TABLE 217 TACONIC BIOSCIENCES, INC.: COMPANY OVERVIEW
    • 12.1.6 JANVIER LABS
    • TABLE 218 JANVIER LABS: COMPANY OVERVIEW
    • 12.1.7 HARBOUR BIOMED
    • TABLE 219 HARBOUR BIOMED: BUSINESS OVERVIEW
    • FIGURE 36 HARBOUR BIOMED: COMPANY SNAPSHOT (2021)
    • 12.1.8 TRANS GENIC INC.
    • TABLE 220 TRANS GENIC INC.: COMPANY OVERVIEW
    • FIGURE 37 TRANS GENIC INC.: COMPANY SNAPSHOT (2021)
    • 12.1.9 INGENIOUS TARGETING LABORATORY
    • TABLE 221 INGENIOUS TARGETING LABORATORY: COMPANY OVERVIEW
    • 12.1.10 POLYGENE
    • TABLE 222 POLYGENE AG: COMPANY OVERVIEW
    • 12.1.11 ARAGEN LIFE SCIENCES LTD.
    • TABLE 223 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
    • 12.1.12 CYAGEN BIOSCIENCES
    • TABLE 224 CYAGEN BIOSCIENCES: COMPANY OVERVIEW
    • 12.1.13 CROWN BIOSCIENCE
    • TABLE 225 CROWN BIOSCIENCE: BUSINESS OVERVIEW
    • 12.1.14 TRANSCURE BIOSERVICES
    • TABLE 226 TRANSCURE BIOSERVICES: COMPANY OVERVIEW
    • 12.1.15 OZGENE PTY LTD.
    • TABLE 227 OZGENE PTY LTD.: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
  • 12.2 OTHER PLAYERS
    • 12.2.1 THE ANDERSONS, INC.
    • 12.2.2 ALLENTOWN, LLC
    • 12.2.3 INNOVIVE
    • 12.2.4 LAB PRODUCTS, LLC.
    • 12.2.5 CRESCENDO BIOLOGICS
    • 12.2.6 IMMUNOGENES
    • 12.2.7 LEXICON PHARMACEUTICALS, INC.
    • 12.2.8 HORIZON DISCOVERY LTD.
    • 12.2.9 MARSHALL BIORESOURCES
    • 12.2.10 APPLIED STEMCELL

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제